Home / Business and Economy / Buffett's Big Bet Sours: UnitedHealth Investment Faces Trouble
Buffett's Big Bet Sours: UnitedHealth Investment Faces Trouble
3 Feb
Summary
- Berkshire Hathaway's major stake in UnitedHealth has lost value recently.
- UnitedHealth faces pressure from Washington and internal issues.
- Buffett's final major stock pick as CEO may be underperforming.
Warren Buffett's final major stock selection as Berkshire Hathaway chief, a substantial stake in UnitedHealth, is encountering difficulties. The investment, built after the health insurer's stock declined, has lost considerable value following a sharp sell-off last week. This decline stems from UnitedHealth reporting lower-than-expected earnings and issuing a cautious future outlook, disappointing Wall Street analysts.
The company is also navigating increased scrutiny from Washington, particularly with the Trump administration proposing flat Medicare Advantage payment rates for 2027. This regulatory pressure is compounded by federal examinations of UnitedHealth's Medicare pricing, the impact of a significant cyberattack, and the recent, shocking killing of its CEO, Brian Thompson, in Manhattan in December 2024. Stephen Hemsley has returned as CEO to lead the company.
While the exact purchase price for Berkshire remains undisclosed, the current stock value is reportedly near or below the acquisition price, indicating potential paper losses. Despite this, any financial setback is considered immaterial for Buffett, who possesses a vast personal fortune. Berkshire Hathaway has a history with UnitedHealth, having held its stock from 2006 to 2009 before divesting.
